Abstract
This small qualitative study was designed to determine possible attitudes toward and understanding of direct-to-consumer (DTC) genetic testing among members of a large managed care organization, and whether differences might exist between population groups. Ten focus groups were conducted by population type (high risk, White, African American, Hispanic/Latino) to determine knowledge, attitudes and beliefs about DTC genetics. Focus group transcripts were coded for attitudes toward and framing of the issue. Study results found participants were negative towards DTC genetic testing but they also found some aspects useful. Participants framed the issue mainly in terms of disease prevention and uncertainty of reaction to results, with some variation between population types. The concept of an “Informed Consumer,” or process to seek information when the issue becomes personally relevant, emerged. This concept suggests that individuals may seek additional assistance to make personally-appropriate choices when faced with a DTC advertisement or genetic test.
Similar content being viewed by others
References
Annes, J. P., Giovanni, M. A., & Murray, M. F. (2010). Risks of presymptomatic direct-to-consumer genetic testing. The New England Journal of Medicine, 363, 1100–1101.
Armstrong, K., Micco, E., Carney, A., Stopfer, J., & Putt, M. (2005). Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA: The Journal of the American Medical Association, 293, 1729–1736.
Bielavitz, S., Wisdom, J., & Pollack, D. (2011). effective mental health consumer education: a preliminary exploration. The Journal of Behavioral Health Services and Research, 38, 105–113.
Bloss, C. S., Ornowski, L., Silver, E., Cargill, M., Vanier, V., Schork, N. J., et al. (2010). Consumer perceptions of direct-to-consumer personalized genomic risk assessments. Genetics in Medicine, 12, 556–566.
Bloss, C. S., Schork, N. J., & Topol, E. J. (2011). Effect of direct-to-consumer genomewide profiling to assess disease risk. The New England Journal of Medicine, 364(6), 524–534.
Bourdieu, P. (1989). Social space and symbolic power. Sociological Theory, 7, 14–25.
Bowen, D. J., Battuello, K. M., & Raats, M. (2005). Marketing genetic tests: empowerment or snake oil? Health Education & Behavior, 32, 676–685.
Cappella, J. N., Mittermaier, D. J., Weiner, J., Humphreys, L. M., & Falcone, T. (2007). “Framing Genetic Risk in Print and Broadcast News: A content analysis” Paper presented at the annual meeting of the NCA 93rd Annual Convention, TBA, Chicago, IL http://www.allacademic.com/meta/p192817_index.html
Caulfield, T. (2006). Introduction: genetic diversity and science communication. Clinical Genetics, 70, 424–426.
Chapman, A. (2008). DTC marketing of genetic tests: the perfect storm. The American Journal of Bioethics, 8, 10–12.
Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20, 37–46.
Collins, F. (2010). Has the revolution arrived? Nature, 464, 674–675.
Collins, F. S., Green, E. D., Guttmacher, A. E., & Guyer, M. S. (2003). A vision for the future of genomics research. Nature, 422, 835–847.
Dearing, J. W., & Rogers, E. (1996). Agenda-Setting. Thousand Oaks: Sage Publications.
Field, A., Krokosky, A., & Terry, S. F. (2010). Direct-to-consumer marketing of genetic tests: access does not reflect clinical utility. Genetic Testing and Molecular Biomarkers, 14, 731–732.
Gamson, W. A. (1992). Talking politics. New York: Cambridge University Press.
Gargiulo, M., Lejeune, S., Tanguy, M. L., Lahlou-Laforet, K., Faudet, A., Cohen, D., et al. (2009). Long-term outcome of presymptomatic testing in Huntington disease. European Journal of Human Genetics, 17, 165–171.
Goddard, K. A., Moore, C., Ottman, D., Szegda, K. L., Bradley, L., & Khoury, M. J. (2007). Awareness and use of direct-to-consumer nutrigenomic tests, United States, 2006. Genetics in Medicine, 9, 510–517.
Goddard, K. A., Robitaille, J., Dowling, N. F., Parrado, A. R., Fishman, J., Bradley, L. A., et al. (2009). Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis. Public Health Genomics, 12, 92–104.
Goddard, K. A. B., Duquette, D., Zlot, A., Johnson, J., Annis-Emeott, A., Lee, P. W., et al. (2009). Public Awareness and Use of Direct-to-Consumer Genetic Tests: Results From 3 State Population-Based Surveys, 2006. American Journal of Public Health, 99, 442–445.
Gulcher, J., & Stefansson, K. (2010). Genetic risk information for common diseases may indeed be already useful for prevention and early detection. European Journal of Clinical Investigation, 40, 56–63.
Gurwitz, D., & Bregman-Eschet, Y. (2009). Personal genomics services: whose genomes? European Journal of Human Genetics, 17, 883–889.
Hall, W., & Gartner, C. (2009). Direct-to-consumer genome-wide scans: astrologicogenomics or simple scams? The American Journal of Bioethics, 9, 54–56.
Hellenthal, N., & Ellison, L. (2008). How patients make treatment choices. Nature Clinical Practice Urology, 5, 426–433.
Hensley, A. S., McBride, C. M., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. (2011). Participation in genetic testing research varies by social group. Public Health Genomics, 14, 85–93.
Howard, H. C., & Borry, P. (2009). Personal Genome Testing: Do You Know What You Are Buying? The American Journal of Bioethics, 9, 11–13.
Hsu, A. R., Mountain, J. L., Wojcicki, A., & Avey, L. (2009). A pragmatic consideration of ethical issues relating to personal genomics. The American Journal of Bioethics, 9, 1–2.
Hudson, K., Javitt, G., Burke, W., & Byers, P. (2007). ASHG statement on direct-to-consumer genetic testing in the United States. The American Journal of Human Genetics, 81(3), 635–637.
Kessler, L., Collier, A., & Halbert, C. (2007). Knowledge about genetics among African Americans. Journal of Genetic Counseling, 16, 191–200.
Kinney, A., Simonsen, S., Baty, B., Mandal, D., Neuhausen, S., Seggar, K., et al. (2006). Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American Kindred. Journal of Genetic Counseling, 15, 293–305.
Kolor, K., Liu, T., Pierre, J., & Khoury, M. J. (2009). Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Genetics in Medicine, 11, 595.
Lee, S. S.-J., & Crawley, L. (2009). Research 2.0: Social Networking and Direct-To-Consumer (DTC) Genomics. The American Journal of Bioethics, 9, 35–44.
Liu, Y., & Pearson, Y. E. (2008). Direct-to-consumer marketing of predictive medical genetic tests: assessment of current practices and policy recommendations. Journal of Public Policy & Marketing, 27, 131–148.
Lowery, J. T., Byers, T., Axell, L., Ku, L., & Jacobellis, J. (2008). The impact of direct-to-consumer marketing of cancer genetic testing on women according to their genetic risk. Genetics in Medicine, 10, 888–894.
Lynch, J., & Condit, C. M. (2006). Genes and race in the news: a test of competing theories of news coverage. The American Journal Health Behavior, 30, 125–135.
MacDonald, C., & Walton, N. (2009). Personal genomics: democratization, or empowerment, or something. The American Journal of Bioethics, 9, 46–48.
Majdik, Z. P. (2009). Judging direct-to-consumer genetics: negotiating expertise and agency in public biotechnical practice. Rhetoric & Public Affairs, 12, 571–605.
Matloff, E., & Caplan, A. (2008). Direct to confusion: lessons learned from marketing BRCA testing. The American Journal of Bioethics, 8, 5–8.
McBride, C. M., Alford, S. H., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. (2009). Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genetics in Medicine, 11, 582–587.
McGowan, M. L., & Fishman, J. R. (2008). Using lessons learned from BRCA testing and marketing: what lies ahead for whole genome scanning services. The American Journal of Bioethics, 8, 18–20.
McGregor, J. L. (2008). Why John Stuart Mill would support restriction on DTC marketing of genetic tests. The American Journal of Bioethics, 8, 9–10.
McGuire, A. L., & Burke, W. (2008). An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA, 300, 2669–2671.
McGuire, A. L., Diaz, C. M., Wang, T., & Hilsenbeck, S. G. (2009). Social networkers’ attitudes toward direct-to-consumer personal genome testing. The American Journal of Bioethics, 9, 3–10.
Mills, C. B., & Erzikova, E. V. (2008). “Prenatal Testing, Disability, and Termination: An Examination of Newspaper Frames” Paper presented at the annual meeting of the International Communication Association, TBA, Montreal, Quebec, Canada http://www.allacademic.com/meta/p232081_index.html
Morgan, D.L. (1997). Focus Groups as Qualitative Research. (2nd Edition). Thousand Oaks, CA: Sage Publications.
Mullineaux, L. G., Castellano, T. M., Shaw, J., Axell, L., Wood, M. E., Diab, S., et al. (2003). Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado. Cancer, 98, 597–602.
Newson, A. J. (2009). Personal genomics as an interactive web broadcast. The American Journal of Bioethics, 9, 27–29.
Ponz de Leon, M., Benatti, P., Di Gregorio, C., Pedroni, M., Losi, L., Genuardi, M., et al. (2004). Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br. J Cancer, 90, 882–887.
Schwartz, M. D., Lerman, C., Brogan, B., Peshkin, B. N., Isaacs, C., DeMarco, T., et al. (2005). Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiology, Biomarkers & Prevention, 14, 1003–1007.
Simon, M. R., & Petrucelli, N. (2009). Hereditary breast and ovarian cancer syndrome: The impact of race on the uptake of genetic counseling and testing. In Mukesh Verma (Ed.), Methods in Molecular Biology, Cancer Epidemiology, 471 (pp. 487–500). New Jersey: Humana Press.
Suther, S., & Kiros, G. E. (2009). Barriers to the use of genetic testing: a study of racial and ethnic disparities. Genetics in Medicine, 11, 655–662.
Ten Eyck, T. A., & Williment, M. (2003). The national media and things genetic: coverage in the New York Times (1971–2001) and the Washington Post (1977–2001). Science Communication, 25, 129–152.
Thompson, H. S., Valdimarsdottir, H. B., Jandorf, L., & Redd, W. (2003). Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women. Patient Education and Counseling, 51, 217–227.
Veenstra, G. (2007). Social space, social class and Bourdieu: Health inequalities in British Columbia, Canada. Health & Place, 13, 14–31.
Wasson, K. (2008). Consumer Alert: Ethical Issues Raised By the Sale of Genetic Tests Directly to Consumers. The American Journal of Bioethics, 8, 16–18.
Wheelwright, J. (2008). The Secret Jews of San Luis Valley. Smithsonian magazine. http://www.smithsonianmag.com/science-nature/san-luis-valley.html. Accessed 1 October 2010.
Wright, C. F., & Gregory-Jones, S. (2010). Size of the direct-to-consumer genomic testing market. Genetics in Medicine, 12, 594.
Yang, Q., Flanders, W. D., Moonesinghe, R., Ioannidis, J. P., Guessous, I., & Khoury, M. J. (2009). Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. American Journal of Human Genetics, 85, 786–800.
Acknowledgments
This study was funded by the National Cancer Institute, contract 5U19 CA079689, “Cancer Research Network Across Health Care Systems” (Edward H. Wagner, MD, MPH, Principal Investigator). The HMO Cancer Research Network (CRN) consists of the research programs, enrollee populations and databases of 14 HMO members of the HMO Research Network. The overall goal of the CRN is to conduct collaborative research to determine the effectiveness of preventive, curative and supportive interventions for major cancers that span the natural history of those cancers among diverse populations and health systems. The 14 health plans, with nearly 11 million enrollees are distinguished by their longstanding commitment to prevention and research, and collaboration among themselves and with affiliated academic institutions. Funding for this study was provided as part of the CRN Pilot program.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rahm, A.K., Feigelson, H.S., Wagner, N. et al. Perception of Direct-To-Consumer Genetic Testing and Direct-To-Consumer Advertising of Genetic Tests among Members of a Large Managed Care Organization. J Genet Counsel 21, 448–461 (2012). https://doi.org/10.1007/s10897-011-9477-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-011-9477-3